The Acute Effects of Meals Rich in Saturated or Unsaturated Fatty Acids on Postprandial Lipaemia in Healthy Men (CocoHeart)

February 21, 2022 updated by: Julie Lovegrove, University of Reading
Current dietary recommendations suggest that lowering intake of saturated fats or replacing it with unsaturated fats will decrease the risk of developing cardiovascular disease. Coconut oil has gained popularity in recent years but it contains 90% saturated fat, which has higher percentage of saturated fat than butter. To date, only limited studies have determined the acute effects of meals containing coconut oil on blood lipids, but findings are inconsistent. Therefore, further studies are needed to address this knowledge gap and compare the postprandial effects of test meals rich in coconut oil with other sources of saturated fatty acids such as butter and unsaturated fatty acids (vegetable oils). A cross-over, double-blind, randomised acute postprandial study will be conducted in 15 healthy men. Participants will be assigned to consume the test meals rich in saturated or unsaturated fatty acids in random order on 3 separate occasions, with 3-4 weeks between each study visit. Participants will be provided with breakfast (toast with jam and milkshake, 50g fat) and lunch (toast with jam and milkshake, 30g fat). The anthropometric, blood pressure, arterial stiffness, and breath samples will be taken for each study visit. Blood samples will be collected for the measurement of fasting lipids, glucose, insulin, inflammatory markers, whole blood culture as well as blood clotting. Breath samples are collected for the measurement of gastric emptying as well as assessment of satiety using questionnaires (100 mm visual analogue scale) completed throughout the day. The findings from this study will contribute to the evidence base on how consuming meals rich in coconut oil influence the level of blood lipids as well as other biomarkers for cardiovascular disease.

Study Overview

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Berkshire
      • Reading, Berkshire, United Kingdom, RG6 6AP
        • Department of Food and Nutritional Sciences, University of Reading

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Healthy men
  • Aged between 30 to 70 years
  • Serum triacylglycerol < 2.3 mmol/l
  • Body mass index between 19-32 kg/m2
  • Total cholesterol < 7.5 mmol/l

Exclusion Criteria:

  • Females
  • Smokers
  • Medical history of myocardial infarction or stroke in the past 12 months
  • Diabetes (defined as fasting glucose > 7.0 mmol/l) or other endocrine disorders
  • Kidney, liver, pancreas or gastrointestinal disorder
  • Hypertension (blood pressure > 140/90 mmHg), cancer, medication for hyperlipidaemia (e.g. statins), hypertension or, inflammation
  • Anaemia (<130 g/L haemoglobin)
  • Taking any dietary supplements known to influence lipids/gut microbiota (e.g. plant stanols, fish oil, phytochemicals, natural laxatives, probiotics and prebiotics)
  • Drinking in excess of 14 units of alcohol per week
  • Planning on a weight-reducing regime
  • Parallel participation in another dietary intervention study
  • Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention and metabolic study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Meal rich in coconut oil
Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in coconut oil
50 g of coconut oil will be added to the test meal for breakfast and 30 g of coconut oil will be added to the test meal for lunch
ACTIVE_COMPARATOR: Meal rich in butter
Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in butter
50 g of butter will be added to the test meal for breakfast and 30 g of butter will be added to the test meal for lunch
ACTIVE_COMPARATOR: Meal rich in vegetable oil
Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in vegetable oil
50 g of vegetable oil will be added to the test meal for breakfast and 30 g of vegetable oil will be added to the test meal for lunch

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in postprandial triacylglycerol
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
Triacylglycerol
Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting blood lipids
Time Frame: Acute study: taken at 0 (baseline)
Total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol
Acute study: taken at 0 (baseline)
Change from baseline in postprandial non-esterified fatty acids
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
Non-esterified fatty acids
Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
Change from baseline in postprandial insulin
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
Insulin
Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
Change from baseline in postprandial vascular stiffness
Time Frame: Acute study: taken at 0 (baseline), 150, 315, 465 minutes
Measured via pulse wave assessment using the Mobil-O-graph device
Acute study: taken at 0 (baseline), 150, 315, 465 minutes
Change from baseline in postprandial blood pressure
Time Frame: Acute study: taken at 0 (baseline), 180, 300, 480 minutes
Systolic and diastolic blood pressure
Acute study: taken at 0 (baseline), 180, 300, 480 minutes
Change from baseline in postprandial thrombin generation
Time Frame: Acute study: taken at 0 (baseline), 180, 330, 480 minutes
Thrombin generation
Acute study: taken at 0 (baseline), 180, 330, 480 minutes
Change from baseline in postprandial gastric emptying
Time Frame: Acute study: taken at 15 minutes intervals between 0 min (baseline) and 480 minutes
Assessed using gas chromatography-mass spectrometry
Acute study: taken at 15 minutes intervals between 0 min (baseline) and 480 minutes
Appetite rating
Time Frame: Acute study: taken at 30 minutes intervals after the test meals up to 8 hours
Assessed using 100 mm visual analogue questionnaire
Acute study: taken at 30 minutes intervals after the test meals up to 8 hours
Change from baseline in postprandial gut hormones
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 120, 240, 330, 360, 390 & 480 minutes
Ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide-1
Acute study: taken at 0 (baseline), 30, 60, 120, 240, 330, 360, 390 & 480 minutes
Change from baseline in postprandial endothelial activation
Time Frame: Acute study: taken at 0 (baseline),180, 300 and 420 minutes
E-selectin, P-selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule-1
Acute study: taken at 0 (baseline),180, 300 and 420 minutes
Change from baseline in postprandial cytokine
Time Frame: Acute study: taken at 0 (baseline),180, 300 and 420 minutes
Interleukin 6, interleukin 1 beta, interleukin 10, tumour necrosis factor alpha, C-C motif chemokine ligand 5, C-X-C motif chemokine ligand 5
Acute study: taken at 0 (baseline),180, 300 and 420 minutes
Weight
Time Frame: Acute study: taken at 0 (baseline)
Body mass index will be calculated (kg/ height in m^2)
Acute study: taken at 0 (baseline)
Body composition
Time Frame: Acute study: taken at 0 (baseline)
Fat mass, fat free mass, trunk fat, trunk fat mass, trunk fat free mass
Acute study: taken at 0 (baseline)
Habitual diet assessment
Time Frame: Prior to the start of the study
4-day food diary
Prior to the start of the study

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Genotyping for apolipoprotein E
Time Frame: Acute study: taken at 0 (baseline)
Single nucleotide polymorphisms related to the metabolism of dietary fats
Acute study: taken at 0 (baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 13, 2020

Primary Completion (ACTUAL)

June 30, 2021

Study Completion (ACTUAL)

September 30, 2021

Study Registration Dates

First Submitted

December 16, 2021

First Submitted That Met QC Criteria

February 21, 2022

First Posted (ACTUAL)

March 3, 2022

Study Record Updates

Last Update Posted (ACTUAL)

March 3, 2022

Last Update Submitted That Met QC Criteria

February 21, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Risk Factor

Clinical Trials on Coconut oil

3
Subscribe